Specialty Rx

Since the 1990s, the number of specialty drugs available on the market has increased exponentially. Employer-sponsored health plans have seen a rise in pharmacy expense due to the increasing availability and costs of these medications. As a result, employers are seeking ways to curb specialty Rx spend.

Download this white paper to learn:

• Approaches to reducing spending
• Compliance and regulatory consequences of those approaches
• Possible solutions and considerations